ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
41,02
-1,94
(-4,52%)
À la fermeture: 08 Juin 10:00PM
41,0695
0,0495
( 0,12% )
Après les heures de négociation: 11:37PM

Novo Nordisk (NVO) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
41,0695
( -4,40% )
Prix Achat
-
Prix Vente
-
Volume échangé
20 647 316
41,00 Fourchette du Jour 42,41
35,12 Plage de 52 semaines 81,44
Cap du marché
Clôture Veille
42,96
Ouverture
42,22
Dernière Transaction
1
@
41.07
Dernière heure de transaction
23:38:08
Volume financier
US$ 858 175 152
VWAP
41,5635
Volume moyen (3 m)
US$ 6 163 492
Actions en circulation
4 432 851 022
Rendement du Dividende (LTM)
11,7 (4,03%)
Ratio Cours sur Bénéfices
10,36
Bénéfice par action (BPA)
27,41
Chiffre d'affairess (LTM)
327,8B
Bénéfice net (LTM)
121,96B

À propos de Novo Nordisk

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, ob... Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Siège social
Bagsvaerd, Denmark
Fondé
2026
Novo Nordisk est coté dans le secteur Healthcare de la New York Stock Exchange avec le ticker NVO. Le dernier cours de clôture d'Novo Nordisk était de US$42,96. Au cours de la dernière année, les actions de Novo Nordisk ont été négociées dans une fourchette de prix de US$ 35,12 à US$ 81,44.

Novo Nordisk compte actuellement 4 432 851 022 actions en circulation. La capitalisation boursière d'Novo Nordisk est de US$182,05 milliard. Novo Nordisk a un ratio cours/bénéfice (ratio PE) de 10.36.

Flux d'options Novo Nordisk (NVO)

Flux global

Haussier

Prime nette

2M

Calls / Puts

264,00%

Ach. / Vent.

84,78%

OTM / ITM

65,45%

Sweeps Ratio

0,00%

NVO Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-4.3205-9.5186164353445.3945.3941.0051376342643.19101323CS
4-5.6005-12.000214270446.6747.7941.0051289814044.7245532CS
123.10958.1915173867237.9647.7935.121615982440.95090736CS
26-6.1305-12.988347457647.264.1635.121992922345.91428321CS
52-34.1305-45.386303191575.281.4435.121804984249.8016299CS
156-117.0405-74.0247296186158.11201.7635.12957456169.28284576CS
260-41.3105-50.146273367382.38201.7635.12626128373.37510398CS

NVO - Frequently Asked Questions (FAQ)

What is the current Novo Nordisk share price?
The current share price of Novo Nordisk is US$ 41,0695
How many Novo Nordisk shares are in issue?
Novo Nordisk has 4 432 851 022 shares in issue
What is the market cap of Novo Nordisk?
The market capitalisation of Novo Nordisk is USD 182,05B
What is the 1 year trading range for Novo Nordisk share price?
Novo Nordisk has traded in the range of US$ 35,12 to US$ 81,44 during the past year
What is the PE ratio of Novo Nordisk?
The price to earnings ratio of Novo Nordisk is 10,36
What is the cash to sales ratio of Novo Nordisk?
The cash to sales ratio of Novo Nordisk is 3,84
What is the registered address of Novo Nordisk?
The registered address for Novo Nordisk is Novo Alle 1, Bagsvaerd, Capital Region of Denmark, 2880
What is the Novo Nordisk website address?
The website address for Novo Nordisk is www.novonordisk.com
Which industry sector does Novo Nordisk operate in?
Novo Nordisk operates in the Biotechnology & Life Sciences sector

NVO Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock